Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 22% ± 4% | |
GABAergic neuron | 3 studies | 29% ± 8% | |
glutamatergic neuron | 3 studies | 40% ± 10% | |
dendritic cell | 3 studies | 23% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1092.34 | 1445 / 1445 | 100% | 27.41 | 183 / 183 |
intestine | 100% | 1112.79 | 966 / 966 | 100% | 24.08 | 527 / 527 |
ovary | 100% | 929.57 | 180 / 180 | 100% | 25.41 | 430 / 430 |
prostate | 100% | 982.20 | 245 / 245 | 100% | 23.98 | 502 / 502 |
stomach | 100% | 802.72 | 359 / 359 | 100% | 25.28 | 286 / 286 |
breast | 100% | 1155.67 | 459 / 459 | 100% | 34.38 | 1117 / 1118 |
bladder | 100% | 1039.90 | 21 / 21 | 100% | 22.02 | 503 / 504 |
uterus | 100% | 1133.66 | 170 / 170 | 100% | 25.64 | 458 / 459 |
thymus | 100% | 1070.74 | 653 / 653 | 100% | 26.12 | 603 / 605 |
kidney | 100% | 805.20 | 89 / 89 | 100% | 23.03 | 897 / 901 |
brain | 100% | 840.85 | 2629 / 2642 | 100% | 23.64 | 705 / 705 |
liver | 100% | 662.65 | 226 / 226 | 100% | 15.84 | 404 / 406 |
lung | 99% | 968.30 | 575 / 578 | 100% | 25.36 | 1155 / 1155 |
adrenal gland | 100% | 1214.02 | 258 / 258 | 99% | 18.15 | 227 / 230 |
pancreas | 98% | 483.21 | 322 / 328 | 99% | 22.51 | 177 / 178 |
skin | 100% | 1558.52 | 1809 / 1809 | 97% | 20.05 | 460 / 472 |
adipose | 100% | 1138.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1036.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.20 | 29 / 29 |
muscle | 100% | 1522.96 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1105.13 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.95 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.80 | 1 / 1 |
heart | 98% | 664.80 | 846 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 14.06 | 75 / 80 |
peripheral blood | 87% | 760.20 | 808 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0090307 | Biological process | mitotic spindle assembly |
GO_0070536 | Biological process | protein K63-linked deubiquitination |
GO_0008608 | Biological process | attachment of spindle microtubules to kinetochore |
GO_0051301 | Biological process | cell division |
GO_0002931 | Biological process | response to ischemia |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0007059 | Biological process | chromosome segregation |
GO_0005813 | Cellular component | centrosome |
GO_0036449 | Cellular component | microtubule minus-end |
GO_0070552 | Cellular component | BRISC complex |
GO_0030496 | Cellular component | midbody |
GO_0005829 | Cellular component | cytosol |
GO_0031616 | Cellular component | spindle pole centrosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0031593 | Molecular function | polyubiquitin modification-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0008017 | Molecular function | microtubule binding |
Gene name | ABRAXAS2 |
Protein name | BRISC complex subunit Abraxas 2 (Abraxas brother protein 1) (Protein FAM175B) |
Synonyms | FAM175B KIAA0157 ABRO1 |
Description | FUNCTION: Component of the BRISC complex, a multiprotein complex that specifically cleaves 'Lys-63'-linked polyubiquitin, leaving the last ubiquitin chain attached to its substrates . May act as a central scaffold protein that assembles the various components of the BRISC complex and retains them in the cytoplasm . Plays a role in regulating the onset of apoptosis via its role in modulating 'Lys-63'-linked ubiquitination of target proteins (By similarity). Required for normal mitotic spindle assembly and microtubule attachment to kinetochores via its role in deubiquitinating NUMA1 . Plays a role in interferon signaling via its role in the deubiquitination of the interferon receptor IFNAR1; deubiquitination increases IFNAR1 activities by enhancing its stability and cell surface expression . Down-regulates the response to bacterial lipopolysaccharide (LPS) via its role in IFNAR1 deubiquitination . Required for normal induction of p53/TP53 in response to DNA damage . Independent of the BRISC complex, promotes interaction between USP7 and p53/TP53, and thereby promotes deubiquitination of p53/TP53, preventing its degradation and resulting in increased p53/TP53-mediated transcription regulation and p53/TP53-dependent apoptosis in response to DNA damage . . |
Accessions | ENST00000298492.6 Q15018 |